WXM:NASDAQWF International Limited Analysis
Data as of 2026-05-11 - not real-time
$0.56
Latest Price
8/10Risk
Risk Level: High
Executive Summary
WF International Limited trades at $0.56, well below its DCF fair value of $0.68 and a price‑to‑book of 0.81, suggesting a potential discount. Technical indicators show a bullish MACD crossover, an RSI of 61.9, and volume trending upward, while the price sits near the upper bound of its support‑resistance range ($0.40‑$0.61). However, the long‑term SMA200 of $1.50 sits far above the current price, indicating a prolonged downtrend.
Fundamentally, the company faces severe challenges: revenue has collapsed by 51.7%, operating margins are –54%, and net earnings are negative with a trailing EPS of –$0.53. Debt‑to‑equity is high at 74%, and while free cash flow is modestly positive, operating cash flow remains negative. Combined with extreme 30‑day volatility (over 100%) and a beta of 1.45, the stock carries substantial risk despite its apparent valuation discount.
Fundamentally, the company faces severe challenges: revenue has collapsed by 51.7%, operating margins are –54%, and net earnings are negative with a trailing EPS of –$0.53. Debt‑to‑equity is high at 74%, and while free cash flow is modestly positive, operating cash flow remains negative. Combined with extreme 30‑day volatility (over 100%) and a beta of 1.45, the stock carries substantial risk despite its apparent valuation discount.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price approaching resistance at $0.61
- high 30‑day volatility (>100%)
- negative earnings and margins
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF fair value ($0.68) exceeds current price
- price‑to‑book below 1 indicates potential upside
- increasing volume suggests renewed interest
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- sustained revenue decline of 51% and heavy debt load
- operating losses and negative cash flow
- elevated regulatory and geographic concentration risk
Key Metrics & Analysis
Financial Health
Revenue Growth-51.70%
Profit Margin-24.54%
ROE-71.91%
ROA-14.05%
Debt/Equity74.20
P/B Ratio0.8
Op. Cash Flow$-1136434
Free Cash Flow$573.5K
Industry P/E29.9
Technical Analysis
TrendNeutral
RSI61.9
Support$0.40
Resistance$0.61
MA 20$0.48
MA 50$0.48
MA 200$1.50
MACDBullish
VolumeIncreasing
Fear & Greed Index90.73
Valuation
Fair Value$0.68
GradeUndervalued
TypeValue
Risk Assessment
Beta1.45
Volatility105.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.